---
title: "Inhibikase Therapeutics (IKT.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/IKT.US/norm.md"
symbol: "IKT.US"
name: "Inhibikase Therapeutics"
parent: "https://longbridge.com/en/quote/IKT.US.md"
datetime: "2026-03-15T21:42:42.685Z"
locales:
  - [en](https://longbridge.com/en/quote/IKT.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/IKT.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/IKT.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/IKT.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/IKT.US/norm.md)


# Inhibikase Therapeutics (IKT.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.1321 | -0.1101 | -0.1520 | -0.1360 | -0.6505 |
| ROE | -62.40% | -47.85% | -60.59% | -102.89% | -1012.35% |
| Revenue | - | - | - | - | - |
| Net income | -11.93M | -9.92M | -13.68M | -12.13M | -5.78M |
| Operating income | -13.26M | -10.83M | -15.76M | -12.93M | -5.83M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 79.59M | 88.85M | 94.28M | 98.60M | 4.38M |
| Leverage | 1.09 | 1.11 | 1.10 | 1.04 | -8.25 |
| BVPS | 0.8071 | 0.8892 | 0.9525 | 1.06 | -0.0711 |
| Turnover | - | - | - | - | 0.0000 |
| Cash & STI | 77.32M | 87.67M | 93.18M | 97.54M | 3.24M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 0.0000 | 58605.00 | 116564.00 | 148537.00 | 186772.00 |
| Net debt | -77.32M | -87.63M | -93.11M | -97.43M | -3.03M |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -10.59M | -5.57M | -4.10M | -5.35M | -4.88M |
| Investing CF | -28.75M | 9.84M | 21.05M | -38.76M | 2.53M |
| Financing CF | -134130.00 | 31771.00 | - | 99.68M | 181954.00 |
| Free CF | -5.89M | -2.40M | -3.47M | -1.19M | -2.46M |
| OCF coverage | - | - | -30625.64% | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | 0.0000 | 0.0000 | -13399.00 | - | - |